New Guidelines Advise Against Using Polygenetic Risk Scores for Routine Patient Management by Glenn S. Demby | Sep 22, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Recent Headlines... This content is for Paid Members only.RegisterAlready a member? Log in here
New ACOG Guidelines Recommend cfDNA-Based NIPT for All Pregnancies, Not Just Risky Ones by Glenn S. Demby | Aug 29, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Inside the Diagnostics Industry-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
Payors Gradually Increasing Coverage of Liquid Biopsies but Obstacles Remain by Glenn S. Demby | Jul 28, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet, Reimbursement-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
Despite Recommendations, Autism Patients Are Not Fragile X, Karyotype or CMA Testing by Glenn S. Demby | May 26, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Testing Trends-dtet... This content is for Paid Members only.RegisterAlready a member? Log in here
New NCCN Recommends Biomarker Prostate Cancer Testing for Intermediate- & High-Risk Men by Glenn S. Demby | Mar 23, 2020 | Articles, Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies... This content is for Paid Members only.RegisterAlready a member? Log in here